FIELD: chemistry.
SUBSTANCE: invention relates to racemic 3-hydroxy-16-methyl-2-fluoro-13α-estra-1,3,5(10),8,15-pentaen-17one of formula 
, which is used as an inducer of high-density lipoproteids, as well as to a method of its obtaining. The method includes reaction of 6-hydroxy-7-fluorotetralone-1 with vinylmagnesium bromide, condensation of formed vinylcarbinol with 2,4-dimethylcyclopentan-1,3-dion with further cyclohydration of the obtained secocompound under action of p-toluenesulfonic acid in toluene.
EFFECT: improved properties of compounds.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-ETHYL-6-OXAESTRA-1,3,5(10),8,14-PENTENES SULFAMATES AS MCF-7 TUMOUR CELLS PROLIFERATION INHIBITORS | 2016 |
|
RU2620084C1 |
| USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM | 2018 |
|
RU2678845C1 |
| 3-METHOXY-2-FLUORO-18-ETHYL-8α-GONA-1,3,5( 10 )-TRIENES, HAVING OSTEOPROTECTOR AND HYPOCHOLESTEREMIC ACTIVITY | 2009 |
|
RU2418000C1 |
| 7β-METHYL-3,17αβ-DISULFAMOYLOXY-D-HOMO-6-OXA-ESTRA-1,3,5(10), 8,14-PENTAEN AS BREAST CANCER MCF-7 CELLS GROWTH INHIBITOR | 2016 |
|
RU2619457C1 |
| RACEMIC 2,17β-DISULFOMOYLOXY-3-METHOXY-8α-EXTRA-1,3,5(10)-TRIENE AS INHIBITOR OF TUMOUR CELL PROLIFERATION OF MCF-7 | 2014 |
|
RU2562242C1 |
| COMPOUNDS WITH HYDROXYCARBONYL-HALOGENALKYL BY-SIDE CHAINS | 2000 |
|
RU2247106C2 |
| DERIVATIVES OF 11β-BENZALDOXIME-ESTRA-4,9-DIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2137777C1 |
| METHOD OF OBTAINING α, ω-{ BIS[(PENTAN-2,4-DION-3-YL)METHYLSULPHANYL]}-ALKANES | 2012 |
|
RU2529514C2 |
| [N'-(ISO)QUINOLYLMETHYLENE]HYDRAZIDES OF 3-METHOXY-13,17-SECOESTRA-1,3,5(10)-TRIEN-17-OIC ACID | 2023 |
|
RU2801166C1 |
| 17-DEOXY-1,3,5-(10)-ESTRATRIENE, METHODS FOR TREATMENT, METHOD FOR SYNTHESIS OF 7-ALPHA-METHYLESTRONE, COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2233288C2 |
